Olaparib Combination Shows Increased Median Overall Survival in Fatal Metastatic Prostate Cancer
February 21st 2023Olaparib with abiraterone increased survival in patients with metastatic prostate cancer compared to the current standard of care, according to a session at the ASCO Genitourinary Cancers Symposium.
Read More
Oncology Pharmacists Bring Value and Contribute to Cancer Care
Oncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
Read More